Maribavir for Prevention of CMV After Stem Cell Transplants

PHASE2CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

October 28, 2004

Primary Completion Date

April 5, 2006

Study Completion Date

April 5, 2006

Conditions
Cytomegalovirus Infection
Interventions
DRUG

Maribavir

DRUG

Placebo

Trial Locations (13)

Unknown

City of Hope Medical Center, Duarte

UCLA Medical Center, Los Angeles

Loyola University, Maywood

Tufts-New England Medical Center, Boston

Wayne State Medical Center, Detroit

University of Minnesota, Minneapolis

Washington University School of Medicine, St Louis

Memorial Sloan-Kettering Cancer Center, New York

Duke Medical Center, Durham

Baylor University Medical Center, Dallas

MD Anderson Cancer Center, Houston

University of Utah, Salt Lake City

Fred Hutchinson Cancer Research Center, Seattle

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Shire

INDUSTRY